CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,273,000 | +2.0% | 352,612 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,248,000 | -8.3% | 352,612 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,361,000 | -27.5% | 352,612 | -17.5% | 0.00% | 0.0% |
| Q2 2016 | $1,877,000 | +16.2% | 427,612 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,616,000 | -82.8% | 427,612 | -28.5% | 0.00% | -80.0% |
| Q4 2015 | $9,378,000 | +33.4% | 598,115 | -10.3% | 0.01% | +25.0% |
| Q3 2015 | $7,032,000 | -58.2% | 667,128 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $16,825,000 | +28.0% | 667,128 | +41.5% | 0.01% | +33.3% |
| Q1 2015 | $13,143,000 | +52.7% | 471,565 | 0.0% | 0.01% | +50.0% |
| Q4 2014 | $8,606,000 | +26.1% | 471,565 | -10.4% | 0.00% | 0.0% |
| Q3 2014 | $6,824,000 | -68.3% | 526,540 | -60.0% | 0.00% | -33.3% |
| Q2 2014 | $21,502,000 | – | 1,317,504 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 876,020 | $31,037,000 | 13.97% |
| Private Capital Advisors, Inc. | 173,191 | $6,136,000 | 2.23% |
| ARDSLEY ADVISORY PARTNERS LP | 265,000 | $9,389,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 944,522 | $33,464,000 | 1.61% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 446,824 | $15,830,000 | 1.09% |
| KOPP INVESTMENT ADVISORS LLC | 72,755 | $2,578,000 | 0.95% |
| EMERALD ADVISERS, LLC | 455,619 | $16,143,000 | 0.91% |
| Cupps Capital Management, LLC | 254,655 | $9,022,000 | 0.58% |
| HealthCor Management, L.P. | 300,000 | $10,629,000 | 0.57% |
| EAM Investors, LLC | 79,486 | $2,816,000 | 0.56% |